Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

How to treat pathologic cell behaviors - Mark Cooper, PhD (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

Hypothyroidism Variants - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Psoriasis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Rheumatoid Arthritis Case Study (2017 Conference) (LDN, low dose naltrexone)

Etiology of rheumatoid arthritis (RA) is autoimmune; has an inflammatory component including food sensitivities. Low Vitamin D a component, as in many diseases. LDN in two cases of RA.

Brian Udell, MD - Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice (2017 Conference) (LDN, low dose naltrexone)